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Substrate recognition and 
catalysis by LytB, a pneumococcal 
peptidoglycan hydrolase involved 
in virulence
Palma Rico-Lastres1,2, Roberto Díez-Martínez2,3, Manuel Iglesias-Bexiga1,2, 
Noemí Bustamante1,2, Christine Aldridge4, Dusan Hesek5, Mijoon Lee5, 
Shahriar Mobashery5, Joe Gray6, Waldemar Vollmer4, Pedro García2,3 & 
Margarita Menéndez1,2
Streptococcus pneumoniae is a major cause of life-threatening diseases worldwide. Here we provide 
an in-depth functional characterization of LytB, the peptidoglycan hydrolase responsible for physical 
separation of daughter cells. Identified herein as an N-acetylglucosaminidase, LytB is involved also 
in colonization and invasion of the nasopharynx, biofilm formation and evasion of host immunity as 
previously demonstrated. We have shown that LytB cleaves the GlcNAc-β-(1,4)-MurNAc glycosidic 
bond of peptidoglycan building units. The hydrolysis occurs at sites with fully acetylated GlcNAc 
moieties, with preference for uncross-linked muropeptides. The necessity of GlcN acetylation 
and the presence of a single acidic moiety (Glu585) essential for catalysis strongly suggest a 
substrate-assisted mechanism with anchimeric assistance of the acetamido group of GlcNAc 
moieties. Additionally, modelling of the catalytic region bound to a hexasaccharide tripentapeptide 
provided insights into substrate-binding subsites and peptidoglycan recognition. Besides, cell-wall 
digestion products and solubilisation rates might indicate a tight control of LytB activity to prevent 
unrestrained breakdown of the cell wall. Choline-independent localization at the poles of the cell, 
mediated by the choline-binding domain, peptidoglycan modification, and choline-mediated (lipo)
teichoic-acid attachment contribute to the high selectivity of LytB. Moreover, so far unknown chitin 
hydrolase and glycosyltransferase activities were detected using GlcNAc oligomers as substrate.
Streptococcus pneumoniae, the pneumococcus, is a Gram-positive aerotolerant bacterium that colonizes 
the nasopharyngeal cavity of children and adults. It is the main cause of several community-acquired 
infections, including bacteraemia, meningitis, pneumonia, and otitis media1,2. This bacterium causes 
1–2 million deaths per year, most of which occur in developing countries3. Sickle-cell anaemia, HIV 
infection, and a variety of chronic organ failure conditions increase the risk of serious pneumococcal 
disease4. The peptidoglycan (PG), a major component of the bacterial cell wall, is essential for shape 
maintenance and protects bacteria from bursting by the turgor5. Typical PG consists of a polymeric 
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network comprised of chains of N-acetylglucosamine-β-(1,4)-N-acetylmuramic acid (GlcNAc-MurNAc) 
connected via short peptides bound to the lactyl carboxyl group of MurNAc. In S. pneumoniae a variable 
proportion of N-acetylglucosamine residues become deacetylated to glucosamine, contributing to the 
bacterial resistance to the action of the host lysozyme, an important element of the innate immunity6,7. 
The pneumococcal cell wall also contains unusually complex (lipo- and wall-) teichoic acids (TAs) with 
covalently linked phosphocholine residues8. The PG is continuously remodelled throughout the cell cycle 
and its complex fine structure illustrates the PG modification and maturation during cell growth7,9. Its 
growth requires the combined action of biosynthetic and hydrolytic enzymes, which makes them appro-
priate targets for the design of novel antibacterials. Pneumococcal cells divide in parallel planes perpen-
dicular to their long axis10 and peripheral PG biosynthesis extends from the middle of dividing cells to 
the equator of what will become the daughter cell, whereas septal biosynthesis creates a PG cross-wall 
between the daughter cells11,12.
LytB is a pneumococcal non-autolytic PG hydrolase identified in our work as a glucosaminidase that 
cleaves the GlcNAc-β(1,4)-MurNAc glycosidic bond of the PG backbone. LytB is responsible for the phys-
ical separation of daughter cells, the final event of cell-division cycle13. Furthermore, it is a virulence fac-
tor involved in the adhesion to and invasion of respiratory epithelial cells14–17, evasion of phagocytosis by 
alveolar macrophages15, and knock-out of the lytB gene decreases by ~45% the ability of R6 cells to form 
biofilms18. Hence, LytB is considered a putative vaccine/drug target. As shown in Fig. 1a, LytB exhibits 
Figure 1. Molecular architecture of the LytB glucosaminidase from S. pneumoniae R6. (a) Scheme of 
LytB domain composition. Red hexagon represents the GH73 domain (LytBGH73), yellow and salmon ellipses 
the SH3b (LytBSH3b) and WW (LytBWW) domains, respectively, which conform LytBCAT. Blue rectangles 
represent the CBRs of the CBD domain (LytBCBD). Numbers indicate the beginning and the end of each 
domain. (b) Cartoon representation of LytBCAT comprising LytBGH73, LytBWW and LytBSH3b domains coloured 
in red, salmon and yellow, respectively. Acidic residues mutated to alanine are shown in stick representation 
except for Asp607 which is located in the flexible region of LytBGH73 and does not appear the X-ray structure 
(carbon atoms in blue, oxygen in red and nitrogen in blue). Non substituted acidic residues of LytBCAT 
located out of the substrate binding groove are depicted in with carbon atoms in green.
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a modular structure that comprises an N-terminal choline-binding domain (LytBCBD) and a C-terminal 
domain (LytBGH73) belonging to the GH73 family of glycoside hydrolases (Pfam entry PF01832). They 
are connected through a WW-like domain (LytBWW) and an SH3b domain (LytBSH3b), both relevant for 
substrate recognition and LytB-mediated host-cell adhesion17. The crystal structure of a LytB fragment 
(LytBCAT) comprising all but the N-terminal LytBCBD domain has been recently reported17. Like the three 
other members of the GH73 family with known structures, LytBGH73 comprises an α -helical domain 
structurally related to those of glycoside hydrolases from families GH19, GH22, GH23 and GH10317,19–21. 
The LytBCBD domain, essential for PG hydrolysis, recognizes the choline moieties of TAs associated to 
the pneumococcal envelope13 and is composed of tandemly arranged choline-binding repeats (CBRs) 
(Pfam accession code PF01473) predicted to form a left-handed β-solenoid, where choline would bind 
at the interface of two consecutive CBRs22–24. The number of LytB CBRs depends on the particular strain, 
ranging from 18 (in the non-encapsulated R6 strain) to 12 (in some atypical strains)25. The physiolog-
ical function of LytB as a PG hydrolase was confirmed by its chain-dispersing activity on long chains 
of LytB-deficient cultures13,17, though the average chain-length of lytB mutant cells might also depend 
on the serotype and growth conditions13,16,17,26. Interestingly, LytB exhibits a rather low specific activity 
on purified pneumococcal cell walls when compared to LytC or LytA (the pneumococcal autolysins) 
and cleaves a limited number of glycosidic bonds13. This partial hydrolysis of purified cell walls and its 
non-autolytic character might indicate a restricted recognition and/or degradation of the PG substrate. 
The structural determinants accounting for this behavior remain however unknown.
In the present work we have investigated the LytB-mediated hydrolysis, including substrate recogni-
tion and specificity, catalytic reaction and cellular localization by using different approaches, i.e., analysis 
of cell-wall degradation products from different pneumococcal strains, in vitro degradation of small PG 
analogues, molecular modelling, and correlation of serial deletions of the LytBCBD domain with cellular 
localization and dispersing activity. Our results reveal that LytB cleaves the GlcNAc-β(1,4)-MurNAc gly-
cosidic bonds and that hydrolysis takes place at PG sites with fully acetylated GlcNAc moieties, with pref-
erence for the uncross-linked muropeptides. The inability of LytB to hydrolyse deacetylated muropeptides 
and the existence of only one single acidic residue (Glu585) essential for catalysis strongly suggests that 
the reaction takes places via a substrate-assisted mechanism, further supporting the notion that GH73 
family enzymes do not share a unique catalytic mechanism21. Furthermore, modelling of LytBCAT bound 
to a hexasaccharide tripentapeptide (GMPP)3 provided structural insights into the substrate-binding 
subsites and into catalysis. We also show that LytB choline-independent localization at the cell poles 
requires the presence of the LytBCBD domain. Together, our data help to understand how the architectural 
complexity of PG hydrolases contributes to finely tune substrate specificity.
Results
Identification of LytB catalytic residues. The LytBGH73 catalytic domain comprises six α-helices 
(α-1 to α-6), a 310 helix (η-2), and a flexible segment of 11-residues connecting helices α-4 and α-5 (from 
Ala605 to Lys615 in the R6 sequence numbering), which was missing in the electron-density maps17 
(Fig. 1b). Though shorter, this flexible segment, together with helix α-4, structurally corresponds to the 
long β-hairpin and loops forming the β-lobe that helps to shape the catalytic groove in Auto and FlgJ 
GH73 glucosaminidases produced by Lysteria monocytogenes and Sphingomonas sp. strain A1, respec-
tively19,20. Members of GH73 family share with structurally related glycoside hydrolases a conserved 
glutamate near the C-terminus of helix α-3 (Glu585 in LytB), proposed as the catalytic proton-donor 
(see Supplementary Fig. S1). In contrast, identification of a second carboxylate which could act as the 
nucleophile that stabilises the oxocarbenium intermediate or forms a covalent intermediate in retaining 
glycosidases, or the general base that activates the water molecule that would attack the oxocarbenium 
intermediate in the inverting enzymes, has been inconclusive with varying results from different pro-
teins and families19–21,27–31. Moreover, the coexistence of inverting and substrate-assisted mechanisms 
in glycoside hydrolases of GH73 family has been suggested recently21. This latter mechanism does not 
require a second catalytic carboxylate as the reaction intermediate is stabilized by the N-acetyl group of 
the sugar moiety at position − 1 (bond cleavage occurs between positions − 1 and + 1) and can account 
for retention of the anomeric configuration during reaction in glycoside hydrolases without a second 
catalytic carboxylate32.
To search for the acidic residue potentially acting either as a nucleophile or a general base during 
catalysis, all aspartic and glutamic acids of LytBGH73 located in the substrate-binding groove or within its 
vicinity (Glu585, Asp596, Asp607, Asp618, Asp619, Asp621, Glu633, Asp637, Glu653, Asp657, Glu662 
and Glu673) were individually replaced by alanine using site-directed mutagenesis (“alanine scanning”). 
The unchanged acidic residues (Glu558, Glu566, Glu568, Glu569 and Asp679) are more than 21 Å away 
or at the opposite face of the catalytic cleft (Fig.  1b). The purified mutant proteins were examined for 
cell-dispersing activity using cultures of R6B, a LytB-deficient strain that forms long chains of cells 
(Fig. 2a,b). Only diplococci and very short chains were observed after treating R6B cultures for 30 min 
with the wild-type LytB (Fig. 2a–c), whereas the cell-chain length remained invariant after 5 h of incuba-
tion with the E585A mutant (Fig. 2d,e), in agreement with its essential role in catalysis in the wild-type 
enzyme17. All the other mutants, except D657A, behaved like the wild-type protein, as illustrated for the 
D619A variant in Fig. 2f, excluding their participation in catalysis. In contrast, addition of the D657A 
mutant resulted in a minor dispersion of daughter cells during the first 30 min of incubation, although 
www.nature.com/scientificreports/
4Scientific RepoRts | 5:16198 | DOi: 10.1038/srep16198
diplococci and very short chains became predominant after a 4.5-h treatment (Fig.  2g,h), revealing a 
significant reduction of the chain dispersion rate. The CD spectra of E585A and D657A mutants super-
imposed with that of the wild-type protein, dispelling the possibility that the activity loss was due to the 
mutant proteins fold differently than the wild-type protein (Supplementary Fig. S2). The Asp657 residue 
belongs to a highly conserved motif (YATD) in GH73 family (Supplementary Fig. S1), making it a good 
candidate for the aforementioned nucleophile/base. However, its distance (7.9 Å) to the carboxyl group 
of the Glu585, the proton donor, is between those reported for retaining (4–5 Å) or inverting (9–11 Å) 
enzymes33.
Furthermore, substitution of the equivalent residue (D1335) in the glucosaminidase domain of 
AtlWM of Staphylococcus warneri by alanine or asparagine yielded nearly fully active mutant proteins27. 
Altogether, these results further indicated the absence of conservation of the nucleophile/base catalyst in 
the GH73 family or, alternatively, the existence of a substrate-assisted mechanism, as has been proposed 
for the GH23, GH103 and GH104 families31.
Substrate Specificity of LytB
Reaction products of in vitro cell-wall degradation. LytB substrate specificity was investigated 
by analyzing the products released by digestion of purified cell walls from pneumococcal strains (R36A, 
R36A::pgdA, R6B, Pen6, Pen6adr and CS1) whose particular characteristics are detailed in Table  1. As 
control, assays were run in parallel with PG cleavage by the muramidase cellosyl, which completely digests 
the pneumococcal PG and, consequently, was previously used to analyse its composition7. The results are 
summarized in Fig. 3, Fig. S3 and Table 2 (peaks were numbered as in Bui et al., 20127). As expected, 
LytB products differed from cellosyl products in that they contained GlcNAc and not MurNAc at the 
reducing end, confirming that LytB is an N-acetylglucosaminidase (Supplementary Fig. S4). Interestingly, 
there were three other major differences between the products generated by the two enzymes. First, 
N-deacetylated species were not detected in the LytB products, but were present, as expected, in those 
of cellosyl that released Tri[deAc], Tetra(S)[Glu/deAc], TetraTri[deAc]‡ and TetraTetraTri[deAc]2[-GM] 
(peaks 2, 10, 17/18, and 29, respectively) among other deacetylated fragments upon digestion of PG from 
the R36A strain. Second, LytB showed a preference for uncross-linked muropeptides (monomers) (peaks 
3′ –16′ ) and the TetraTri dimer (peak 19′ ), whereas dimers with Ser-Ala or Ala-Ala bridges, and even 
Figure 2. Chain dispersing activity of the wild type and alanine mutants of LytB. R6B cultures 
(OD550 ~ 0.2) were treated at 37 °C with the purified proteins (10 μ g/ml) and aliquots were removed, at 
different times, to examine the culture morphology and determine the average chain length by using phase-
contrast microscopy. (a) Chain dispersion by LytB wild type (white bars), E585A (hatched bars) and D657A 
(vertical-stripped dark-grey bars) LytB mutants. Untreated cells (black bars), used as controls, were also 
examined. Error bars represent standard deviations. (b) Morphology of untreated cells. (c,d,f,g) Morphology 
of cells after 30 min of incubation with LytB wild type, D585A, D619A or D657A mutants, respectively.  
(e,h) Morphology of cells after 4.5 h of incubation with D585A or D657A mutants, respectively. Bars, 25 μ m.
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Strain Description Source/reference
S. pneumoniae
 R36A Non-encapsulated laboratory strain 67
 R36A::pgdA Mutant derivative of strain R36A. Gene encoding peptidoglycan GlcNAc deacetylase is inactivated. Absence of N-deacetylated muropeptides 6
 R6 Derivative of the rough, non-encapsulated strain R36A 68
 R6B R6 deficient mutant in lytB gene (R6 (lytB::ermC)) 69
 Pen6 High β -lactam resistance transformant enriched in branched muropeptides 70
 Pen6adr Mariner insertion in adr of Pen6. Enriched in branched muropeptides. Lower resistance to β -lactam antibiotics. No O-acetylation. 71
 CS1 dacA mutant pentapeptide rich 72
E. coli
 BL21 (DE3) F− bmpT gal [cdm] [lon] hsdSb with DE3 73
Plasmids
 pT7-7 Apr 52
 pRGR5 pT7-7 derivative encoding LytB wild type, Apr 13
 pRGR5E585A pT7-7 derivative encoding LytB E585 mutant, Apr This study
 pRGR5D596A pT7-7 derivative encoding LytB D596A mutant, Apr This study
 pRGR5D607A pT7-7 derivative encoding LytB D607A mutant, Apr This study
 pRGR5D618A pT7-7 derivative encoding LytB D618A mutant, Apr This study
 pRGR5D619A pT7-7 derivative encoding LytB D619A mutant, Apr This study
 pRGR5D621A pT7-7 derivative encoding LytB D621A mutant, Apr This study
 pRGR5E633A pT7-7 derivative encoding LytB E633A mutant, Apr This study
 pRGR5D637A pT7-7 derivative encoding LytB D637A mutant, Apr This study
 pRGR5E653A pT7-7 derivative encoding LytB E653A mutant, Apr This study
 pRGR5D657A pT7-7 derivative encoding LytB D657A mutant, Apr This study
 pRGR5E662A pT7-7 derivative encoding LytB E662A mutant, Apr This study
 pRGR5E673A pT7-7 derivative encoding LytB E673A mutant, Apr This study
 pRGR25B pT7-7 derivative encoding fusion protein GFP-LytB, Apr 13
 pTRDGB1 pT7-7 derivative encoding fusion protein GFP-LytBΔ 1, Apr This study
 pTRDGB2 pT7-7 derivative encoding fusion protein GFP-LytBΔ 2, Apr This study
 pTRDGB3 pT7-7 derivative encoding fusion protein GFP-LytBΔ 3, Apr This study
 pTRDGB4 pT7-7 derivative encoding fusion protein GFP-LytBΔ 4, Apr This study
 pTRDGB5 pT7-7 derivative encoding fusion protein GFP-LytBΔ 5, Apr This study
Table 1.  Bacterial strains and plasmids used in this study.
trimers, represented a higher percentage of the reaction products in the hydrolysis with cellosyl (peaks 
23, 25, 39 and 31). Third, LytB release of early eluting, putative non-substituted glycan chains (fractions 
C1 to C2), was around 10 times higher than with cellosyl (Table 2) and markedly increased in R6B lysates. 
Accordingly, digestion of cell walls or PG from R36A::pgdA containing full acetylation of GlcNAc moie-
ties resulted in more similar profiles by raising the relative contribution of Tri, TetraTri and Tetra(SA)Tri 
muropeptides (peaks 3′ , 19′ and 23′ , respectively) in LytB products, and the amount of material solubi-
lised by the pneumococcal glucosaminidase was almost doubled with respect to the R36A strain (~66% 
of that of the cellosyl digest for the R36A::pgdA strain). Furthermore, LytB and cellosyl solubilised to a 
similar extent the branched Tri(SA) and Tri(AA) monomers (fractions 12/12′ and 14/14′ , respectively), 
which are enriched in strain Pen6 and Pen6adr, but LytB failed to efficiently release the branched dimers 
or trimers (the cellosyl products 29, and 31). Cross-linked muropeptides became almost undetectable 
also in the reaction products of LytB with the cell wall of the pentapeptide-rich CS1 mutant (Fig. 3 and 
Table 2), but not for cellosyl, and the Penta muropeptide (peaks 7/7′ ) became the predominant species. 
Of note, the amount of cell walls solubilised by LytB was ~50% higher for the CS1 mutant than for R36A. 
The lower abundance of putative unsubstituted glycan chains in cellosyl digests could be explained, at 
least partially, by the overall more material released by this enzyme. Hence, these data show that LytB 
cleaves PG at sites with fully acetylated GlcNAc residues with preference for monomeric peptides, with 
or without branches, and is less active at sites with peptide cross-links. Moreover, in vitro degradation of 
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cell walls labelled with [methyl-3H]choline showed that prior cleavage of peptide stems by the LytA ami-
dase increased the specific activity of LytB by around 4-fold (from 600 ± 60 U/mg to 2,500 ± 600 U/mg; 
average of five independent experiments), indicating that removal of the stem peptides, or the resulting 
increase in size of the cell wall pores, facilitated the catalytic action of LytB. This activity is lower than 
that of LytA (~2.5 × 105 U/mg) but in the order of that of LytC (~6,000 U/mg)13.
Cleavage of PG structural analogues. The complexity of cell-wall hydrolysis by LytB abrogates 
its use in investigation of the reaction mechanism. With this aim in mind we tested the capacity of 
LytB to cleave small compound surrogates of PG components (see Supplementary Fig. S5). First, the 
N-acetylglucosamine oligomers (GlcNAc)4 and (GlcNAc)5 were used as substrate because of LytB struc-
tural relationship with chitinases and lysozymes with chitin hydrolase activity34. LytB cleaved both oligo-
saccharides but products were only detected after several hours of incubation (Fig. 4 and Supplementary 
Fig. S6), indicating that productive-complex formation required a slow rearrangement of either the free 
protein or previously formed non-productive complexes29. Subsequently, the reaction advanced relatively 
rapidly and all possible digestion intermediates were identified using HPLC and MALDI-TOF yielding, 
with both substrates, GlcNAc as final product (Fig.  4 and Supplementary Fig. S6). Nevertheless, after 
30 h of incubation GlcNAc and (GlcNAc)3 or (GlcNAc)4 were the principal products of (GlcNAc)4 or 
(GlcNAc)5 hydrolysis, which indicated preferential occupancy of subsites − 1 to + (n− 1) and/or − (n− 1) 
to + 1 by the substrate. GlcNAc oligomers were also hydrolysed by the D657A protein mutant, albeit at 
lower rate than by the wild-type enzyme, as shown for (GlcNAc)4 in Supplementary Fig. S7, in agreement 
with the effect of this mutation on cell chain dispersing activity.
Of note, several new peaks eluting after that of the initial substrate were observed in the presence of 
LytB, their molecular masses being compatible with the incorporation of one or two GlcNAc units to the 
initial substrate (Fig. 4c and Supplementary Fig. S6). The simplest interpretation of these results is that 
LytB can also catalyze the glycosyltransfer reaction, though less efficiently than the hydrolysis considering 
the relative intensity of respective products. This activity, also reported for certain derivatives of HEWL 
and T4 lysozymes35,36, has only been observed in retaining enzymes32. Future investigations will shed 
light if the same applied to LytB.
The cleavage of small muropeptides was also tested using GlcNAc-MurNAc-L-Ala-D-γ -Gln (GMDP), 
GlcNAc-MurNAc(OCH3)-L-Ala-D-γ -Glu-L-Lys-D-Ala-D-Ala (GMPP) and GlcNAc-MurNAc-GlcNAc- 
MurNAc(OCH3) (GM)2 as substrates. The analysis of the reaction mixtures revealed that only 
the tetrasaccharide is recognized as substrate by LytB (Supplementary Figs. S8 and S9), yielding 
GlcNAc-MurNAc-GlcNAc and MurNAc(OCH3) as the sole reaction products, as confirmed by LC/MS 
and LC/MS/MS (Supplementary Fig. S9). Conversion was very slow (~ 10% turnover in 48 h) but clearly 
documents that the tetrasaccharide is the smallest fragment of the PG glycosidic chain recognised as 
substrate by LytB, that the tetrasaccharide occupies subsites − 3 to + 1, and that cleavage corresponds to 
an unequivocal glucosaminidase reaction. The poor turnover rate of LytB of this substrate might be due 
to the presence of the negatively charged carboxylates of the MurNAc residues.
Definition of substrate-binding subsites and modelling of PG binding to LytBCAT. The best 
structural agreement between LytBGH73 and the related structures of the GH23 family (the closest rel-
atives identified by the Dali server37) corresponds to the region defining the substrate-binding groove 
(helices α -3 and α -5), including the proton-donor and the aromatic residues that help to create an envi-
ronment that favours catalysis at physiological pH17,19–21,28 (Supplementary Fig. S10). Moreover, super-
imposition of LytBGH73 with the related GH23 structures containing substrates or inhibitors at the active 
site revealed a good fit of the ligands into the substrate-binding groove of LytB (Supplementary Fig. S10) 
and allowed identification of at least 5 different subsites in its catalytic cavity, from positions − 3 to + 2 
(the reducing end), with the saccharide units flanking the scissile bond (positions − 1 and + 1) close to 
Glu585, the proposed proton donor. The saccharide unit at position − 4 in GH23 complexes would be 
out of the LytBGH73 catalytic groove.
To provide a basis for better understanding of the substrate recognition at the molecular level we 
performed docking studies using first GlcNAc-MurNAc-L-Ala as ligand. The 10 low-energy complexes 
found by AutoDock for GlcNAc-MurNAc-L-Ala bound to LytBCAT placed the GlcNAc and MurNAc 
moieties at subsites − 1 and + 1 of GH23 complexes (hereafter GlcNAc− 1 and MurNAc+ 1; see Fig. 5a). 
In the best-scoring energy pose of the cluster, the carboxylate oxygen of Glu585 is at hydrogen-bond 
distance of GlcNAc− 1 O5 and O6 hydroxyl oxygens and at 4.0 Å from the anomeric oxygen, with the 
suitable orientation for involvement in catalysis. Two additional hydrogen bonds by Ser656 and Phe601 
contribute to GlcNAc−1 recognition. The N-acetyl group of MurNAc+ 1 also established hydrophobic 
and polar interactions with Leu584 and Asn587, respectively, whereas the lactyl moiety makes hydro-
phobic contacts with Lys663 and Trp660 residues, and the side-chain of Asp657 (relevant for catalysis) 
is bridged to the attached L-Ala. Equivalent contacts have been described for the sugar unit at position 
− 138,39 and the N-acetyl group of the sugar unit at position + 140,41 in several complexes of GH23 fam-
ily. The partially conserved, intricate network of substrate-protein interactions here predicted for the 
GlcNAc-MurNAc-L-Ala/LytBCM complex supports the notion that our model is plausible.
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Subsequently, a larger PG structure was modelled into the substrate-binding cavity by double 
superimposition of the tetrasaccharide di-pentapetide GlcNAc-MurNAc(-L-Ala-D-γ -Glu-L-Lys-D-
Ala-D-Ala)-GlcNAc-MurNAc(-OCH3)(-L-Ala-γ -D-Glu-L-Lys-D-Ala-D-Ala) ((GMPP)2) structure onto 
the GlcNAc-MurNAc-L-Ala/LytBCAT complex. The final model revealed contacts for the six saccharide 
units occupying the binding cleft (from positions − 3 to + 3), but the MurNAc unit at subsite + 3 was 
nearly out of the cavity (Fig. 5b,c). The glycan strand retained the helical conformation found in solution 
for (GMPP)242, MurNAc + 1 and GlcNAc− 1 keep the orientation and contacts found in the previous 
model, and the saccharide units at subsites + 2, − 2 and − 3 were docked as expected from the super-
imposition of LytBCAT with the GH23 complexes shown in Supplementary Fig. S9. Contact inspection 
showed that the glycan strand is hydrogen-bonded to 13 functionalities from 10 different residues (Table 
S3) and make about 10 favourable hydrophobic interactions (Fig. 5b,c), a high proportion of which are 
concentrated at subsites + 1 to − 2. Thus, MurNAc− 2 is involved in polar or hydrophobic interactions 
with several residues from the LytBSH3b (Tyr429) and LytBGH73 (Gly602, Ile603 and Thr604) domains, 
largely mediated by the sugar N-acetyl group (Fig. 5c). Relevant contacts at subsites + 2 and − 3 further 
document the importance of N-acetylation for the PG recognition by LytB. Thus, the N-acetyl group of 
GlcNAc+ 2 interacts with a number of residues from helix α-4, while that of GlcNAc− 3 can mediate 
contacts with residues close to the conserved YASD tetrad of the GH73 family (Fig.  5b,c and Table 
S3). Atoms from the main chain and the side chains of the pentapeptides bound to MurNAc+ 1 and 
MurNAc− 2 would also make favourable contacts with several protein residues (Fig. 5b and Table S3), 
but that of MurNAc+ 3 appears to be completely exposed to the solvent. The hydrogen bonds mediated 
by the MurNAc+ 1 pentapeptide, docked at the interface of LytBSH3b and LytBWW domains, expand to 
side chains of residues belonging to the three domains of LytBCAT, whereas the MurNAc− 2 pentapeptide, 
laying within a hydrophobic cavity of LytBGH73 limited by helix α -5 and the flexible segment connecting 
Figure 3. Comparison of the pattern of PG fragments released with LytB or cellosyl from cell wall 
or PG from different pneumococcal strains. Reduced PG fragments solubilized by PG-digestion with 
cellosyl or cell-wall digestion with LytB were separated on a Prontosil C18 column, and the OD205 of the 
eluate was monitored. Peaks obtained with cellosyl, used as a control of PG muropeptide composition, are 
numbered as in Bui et al. 20127. Corresponding structures of the LytB-released fragments (marked with 
apostrophes) have similar retention time but differ in the sugar at the reducing end (N-acetylglucosaminitol 
for LytB vs. N-acetylmuramitol for cellosyl; see Supplementary Fig. S4). PG fragment structures are shown 
in Supplementary Fig. S3. Labels with asterisks indicate deacetylated muropeptides and those underlined 
correspond to peaks analyzed by MS (see Supplementary Table S2). The structures corresponding to C1-C2 
peaks could not be determined due to the co-elution of phosphate from the sample buffer, which interferes 
with ESI-MS/MS analysis.
www.nature.com/scientificreports/
8Scientific RepoRts | 5:16198 | DOi: 10.1038/srep16198
α -4 to α -5, could bind through hydrogen bonds and hydrophobic contacts to residues of helices α-3 and 
α-5 and the loop connecting α-4 to α-5 (see Supplementary Fig. S11 and Table S3).
Determinants of LytB cellular localization. As LytB harbours the highest number of CBRs among 
the pneumococcal choline-binding proteins (18 repeats in LytB from R6 strain) and choline plays a key 
role in the bacterial physiology and the enzymatic activity of PG hydrolases, we investigated the par-
ticipation of the CBRs in LytB cellular localization and activity. In this vein, recombinant genes coding 
for chimeric proteins containing the green-fluorescent protein (GFP) fused to the full-length protein or 
serial truncated mutants with 15, 13, 8 and 4 CBRs or just LytBCAT (Fig. 6a) were cloned and the cor-
responding proteins purified to electrophoretic homogeneity. Each LytB variant was exogenously added 
to an R6B culture to test both its localization on pneumococcal cells and its capacity to disperse the 
long cell chains, using the untreated culture as control (Fig. 6b). These experiments show that the flu-
orescence signals of full-length GFP-LytB and truncated GFP-LytBΔ 1, GFP-LytBΔ 2, GFP-LytBΔ 3 and 
GFP-LytBΔ 4 proteins (with 18, 15, 13, 8 and 4 CBRs, respectively) have a preferential polar localiza-
tion, although dispersed localization over the cell hemispheres was also observed (Fig. 6c–g). However, 
the cell de-chaining capacity of these constructions depended on the length of the LytBCBM: GFP-LytB, 
GFP-LytBΔ 1 and GFP-LytBΔ 2 displayed the same chain-dispersing activity, while that of GFP-LytBΔ 3 
was slightly reduced and GFP-LytBΔ 4 moderately decreased the length of cell chains (Fig.  6i). In 
contrast, no binding nor dispersion was detected with the GFP-LytBCAT protein lacking all the CBRs 
(Fig. 6h,i). Bai et al., (2014) have previously reported that LytBCAT could disperse cell chains of a TIGR4 
lytB mutant17, which might be due to the moderate cell chain length of this mutant and the use of 10-fold 
higher protein concentration in their assays. It is noteworthy that LytB deletion variants without GFP 
had the same chain-dispersing capacity than the corresponding GFP-constructions, confirming that the 
N-terminal GFP tag did not interfere with the catalytic activity.
The dependence of LytB binding and activity on the aminoalcohol incorporated in TAs was also exam-
ined using the R6 wild-type strain grown in chemically defined media containing either choline or its 
chemical analogues N-N-dimethylethanolamine (DEA), N-methylethanolamine (MEA) or ethanolamine 
(EA). As shown in Fig. 7a–c, the GFP-LytBΔ 1 protein binds to defined zones of all types of cells with 
low spreading of the fluorescent signal over the cell hemispheres. The cell-dispersing activity of GFP-LytB 
and the truncated constructs was checked also on the same DEA-, MEA- and EA-grown cells. As shown 
in Fig. 7d, the GFP-fusion proteins displayed the same activity graduation seen on choline-grown cul-
tures when tested on DEA cells (i.e. a partial decrease of the chain length that increased with the LytBCBD 
length) and no de-chaining activity on MEA and EA cells. Taken together, these experiments revealed 
that (i) the exogenously added protein is primarily located on polar regions, with similar patterns for 
Relative area (%)
Streptococcus pneumoniae strain
R6B R36A R36A::pgdA Pen6 Pen6adr CS1
putative glycan chains (8–24 min)
 Cellosyl 8.4 4.1 5.3 2.6 3.1 14.5
 LytB 31.6 25.9 16.9 17.0 23.5 26.5
unbranched monomers (24–42 min)
 Cellosyl 34.1 25.7 26.0 4.5 10.9 29.7
 LytB 33.5 29.1 29.4 22.5 22.6 38.7
branched monomers (42–60 min)
 Cellosyl 11.4 15.0 7.4 44.9 37.4 16.4
 LytB 20.9 23.4 17.2 34.0 26.2 17.3
directly crosslinked dimers (60–69 min)
 Cellosyl 18.2 18.1 23.4 4.3 3.6 6.7
 LytB 6.8 8.8 13.0 6.8 9.8 7.7
bridged, branched and bridged-branched dimers (69–88 min)
 Cellosyl 25.6 32.2 28,9 37.2 42.4 31.6
 LytB 7.0 11.9 19.5 17.8 16.6 9.2
trimers (88-end min)
 Cellosyl 2.3 4.8 8.9 6.4 2.7 1.1
 LytB 0.5 1.0 3.1 1.9 2.1 0.7
Table 2.  Percentages of different soluble products released from the cell wall or PG by LytB or cellosyl, 
respectively, determined by HPLC.
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constructs containing from 18 to 4 CBRs, although the activity of the mutant with only 4 CBRs is 
significantly impaired; (ii) binding to and localization on pneumococci do not depend on the nature 
of the amino-alcohol decorating the bacterial TAs but requires the presence of the CBRs; and (iii) the 
dispersing activity was totally dependent on the presence of choline — or a tertiary-aminoalcohol — in 
the culture media.
Discussion
Typical pneumococci grow as diplococcal or short chained cells and these forms are governed by the cor-
rect function of the LytB glucosaminidase. The direct consequence of lytB gene knockout is the formation 
of long cell chains13,16,17,26, but also impairments to biofilm formation18,43, respiratory track colonization 
and infection14,15,17, and evasion of host immunity15, although the precise effect of lytB gene inactivation 
might depend on serotype and growth conditions13,16,17,26. Separation of daughter cells entails cleavage 
of the glycosidic bonds of PG backbone units, and full integrity and activity of LytB is also important 
for lung epithelial cell colonization and infection17. We have documented that LytB is a cell-wall glu-
cosaminidase that can also hydrolyse soluble GlcNAc oligomers and displays a small, but detectable, gly-
cosyltransferase activity, but the physiological relevance of these new activities is not yet clear. However, 
considering that the pneumococcal biofilm matrix contains a polysaccharide with β-(1,4)-GlcNAc units 
and is highly sensitive to the action of chitinases41, these activities might be related to enhanced bio-
film formation at low concentrations of LytB (≤ 0.5 μ g/ml) and/or the ability to disintegrate biofilms at 
concentrations ≥ 5 μ g/ml41. The existence of cell-associated LytB− eDNA complexes in S. pneumoniae 
biofilms has been also reported44.
The failure of LytB to hydrolyze the smaller muropeptides GMDP and GMPP could denote the impor-
tance of individual binding sites for natural PG recognition and, consequently, a non-productive mode 
of binding29. Moreover, the (GM)2 tetrasaccharide is shown to be the smallest PG fragment hydrolyzed 
by LytB. Besides, its cleavage pattern unveils preferential binding to positions − 3 to + 1. We also noted 
that the trisaccharide that is generated from turnover of (GM)2 is not a substrate for the enzyme, which 
underscores the importance of occupation of these subsites for the catalytic competence of the enzyme. 
When compared with (GlcNAc)4 or (GlcNAc)5 hydrolysis reactions, these results also denote that the 
lactyl moieties of (GM)2 determine the feasible positioning in the active site.
Modelling of the (GMPP)3 muropeptide in complex with LytBCAT has provided a first insight into 
the subsite structure of the catalytic cavity and the respective ligand− protein contacts. According to 
the model, the binding groove could accommodate up to six saccharide units (subsites − 3 to + 3) and 
the entire pentapeptides of MurNAc-2 and MurNAc+ 1. Interactions between LytBCAT and MurNAc+ 3 
are apparently minor, but its recognition by the LytBCBD domain cannot be dismissed. Protein contacts 
are primarily provided by the LytBGH73 domain, but the saccharide units at subsites − 3 and − 2 are also 
Figure 4. HPLC and MALDI-TOF analysis of (GlcNAc)4 products upon treatment with LytB. The 
reaction was carried out at 37 °C in Pi buffer, pH 7.0. Aliquots of the reaction mixture were withdrawn at 
different incubation times and compounds were detected following the absorbance at 205 nm (arbitrary 
units). (a) Incubation of (GlcNAc)4 (84 μ M) with LytB (4.2 μ M). The substrate and products formed during 
the reaction are shown at the top. (b) Deconvolution of the elution profile after 30 h of incubation from 
panel (a). (c) Detection of transglycosilation products by HPLC and MALDI-TOF after 30 h of incubation 
of (GlcNAc)4 (1.5 mM) with LytB (4 μ M). Product masses (m/z) correspond to the [M + Na]+ species of 
(GlcNAc)5 and (GlcNAc)6 together with the hydrolysis products. Monoisotopic masses [M + Na]+ are 
presented for each of the compounds detected. Controls without protein at the longest incubation time are 
shown (C traces). Peak labels indicate the number of GlcNAc units and the anomeric form (α or β ) of each 
species, assigned by using GlcNAc oligomers (n = 1–6; 300 μ M each) as standards (S trace).
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stabilized by residues from the LytBSH3b domain, which participates together with LytBWW in recognition 
of the MurNAc+ 1 pentapeptide. These observations agree with the relevance of the last three domains 
of LytB for the PG hydrolase activity17, and its capacity to efficiently hydrolyze Tri, Tetra and Penta 
monomers. The carboxylic oxygen of the proton donor (Glu585) is located at 4.0 Å from the anomeric 
oxygen of GlcNAc− 1 and at 7.9 Å from the carboxylic group of Asp657, the only other acidic residue 
relevant for the activity, which in turn is at hydrogen-bond distance of the main-chain amine of L-Ala 
of the MurNAc+ 1 pentapeptide.
Identification of the soluble reaction products after cell-wall digestion by LytB, and their comparison 
with those released in parallel by cellosyl, have shown that the glucosaminidase is highly specific for 
Figure 5. Models of LytBCAT complexes with PG analogues. (a) Surface representation of the LytBCAT/
GlcNAc-MurNAc-L-Ala complex generated by AutoDock 4.2. Saccharide units are docked into + 1/− 1 
subsites of the binding site. The ten lower energy solutions obtained are drawn in line representation. The 
inset shows the contact network at subsites + 1 and − 1 for the best docking complex. Dashed lines indicate 
the hydrogen bonds and the residues involved are shown as red (LytBCAT) or green (ligand) sticks.  
(b) Putative interactions between the domains of LytBCAT and (GMPP)3 (green sticks) in the computational 
model created by extending the best docking solution for the LytBCAT/GlcNAc-MurNAc-L-Ala complex. 
Protein residues involved in hydrogen bond formation are depicted as sticks. (c) Schematic representation 
of contacts between LytBCAT and (GMPP)3 glycan strand analyzed with LigPlot+ v.1.465. Van der Waals 
interactions are shown with black arcs. The catalytic Glu585 and the conserved YASD tetrad are highlighted 
with red ovals, and the zig zag line indicates the scissile bond. The same colour code was used in the whole 
figure: GlcNAc-MurNAc-L-Ala and (GMPP)3 are depicted in green, whereas LytBGH73, LytBSH3b and LytBWW 
domains are in red, yellow and salmon, respectively.
www.nature.com/scientificreports/
1 1Scientific RepoRts | 5:16198 | DOi: 10.1038/srep16198
fully N-acetylated substrates, and preferentially cleaves uncross-linked muropeptides (with and with-
out a dipeptide branch) or directly cross-linked TetraTri dimers. Accordingly, the amount of material 
released upon digestion of R36A::pgdA fully-acetylated cell-walls was almost doubled compared to R36A, 
with a clear increase in the proportion of fully acetylated TetraTri and Tetra(SA)Tri muropeptides. The 
differential distribution of GlcN residues in the pneumococcal PG (45.1% in dimeric muropeptides vs 
18.5% in monomers and 14.2% in trimers7) could partially explain the higher resistance of dimers to 
LytB hydrolysis in deacetylated strains but not of trimers. The flexible region of LytBGH73 (not visible in 
the crystal structure and shorter than those of Auto and FlgJ glucosaminidases) or the LytBCBD domain, 
whose positioning in the overall protein structure remains unknown, might hamper binding of trimers 
or peptide-bridged-branched dimers that were almost undetected in the reaction products of all the 
cell walls tested. On the other hand, unsubstituted glycan chains, susceptible to LytB action, might be 
enriched in the thin filaments of cell wall holding together the daughter cells, as suggested its higher 
proportion in cell walls of R6B strain. It is worth noting that LytB was completely unable to disperse 
the long chains formed by a PBP2b depletion mutant whose PG was enriched in branched cross-linked 
muropeptides with respect to that of wild-type cells45. Interestingly, the significant decrease in adhesion 
to and invasion into lung epithelial cells caused by mutation of the catalytic proton donor to glutamine17, 
might show a correlation between virulence and LytB substrate specificity. In addition, pneumolysin 
release from cell-wall compartment is controlled by the increase of branched cross-linked muropeptides 
and depends, at least partially, on PG remodelling by non-lytic choline-binding hydrolases46,47, which 
makes it tempting to speculate that LytB might contribute to pneumolysin release into the surrounding 
medium.
At the molecular level, two different factors would account for the resistance of deacetylated sub-
strates to LytB catalysis: (i) a direct participation of the N-acetyl moiety of GlcNAc− 1 in catalysis, act-
ing as the nucleophile through a substrate-assisted mechanism, and/or (ii) a key role of the N-acetyl 
moieties of GlcNAc in substrate recognition by the active site. The finding of a single acidic residue, 
Glu585, essential for the activity strongly indicates that the LytB-mediated hydrolysis might take place 
via a substrate-assisted catalysis, with Glu585 acting as the general acid and the carbonyl oxygen of 
the N-acetyl group of GlcNAc− 1 as the nucleophile, thereby accounting for its critical role in activity. 
Nonetheless, according to the structure proposed for the LytBCAT/(GMPP)3 complex, the N-acetyl moi-
eties of the GlcNAc units bound at subsites − 3 and + 2 are also involved in binding and would further 
contribute to the selectivity of PG recognition. In this context, the predicted participation of Asp657 in 
Figure 6. Localization of different GFP-LytB deletion proteins at the surface of S. pneumoniae and their 
dispersing chain activity. (a) Scheme of LytB deletion mutants fused to the GFP. Symbols have the same 
meaning as in Fig. 1a. (b–h) R6B cultures (OD550 ~ 0.15) were treated at 37 °C with the purified proteins 
(9 μ g/ml) and observed at the microscope, with or without fluorescence, after 30 min of incubation.  
(b) control of untreated cell culture (c) GFP-LytB; (d) GFP-LytBΔ 1; (e) GFP-LytBΔ 2; (f) GFP-LytBΔ 3;  
(g) GFPLytBΔ 4; (h) GFP-LytBCAT. (i) Average chain length of R6B cells after 30 min of incubation with the 
different proteins. Error bars represent standard deviations, and asterisks mark results statistically significant 
compared to the control in the absence of protein (one-way ANOVA with a post hoc Dunnet test; *P < 0.01). 
Bars, 4 μ m.
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substrate binding would explain the slower cell dispersion observed for the D657A mutant. We further 
note that any of these interactions, even those remote from the seat of reaction, could contribute to sol-
vation of the substrate within the active site. The immediate consequence of this could be manifested in 
lowering of the energy barrier for the critical transition-state species for the reaction catalysed by LytB.
The selectivity of LytB for fully acetylated substrates does not seem to be inherent to the entire family 
GH73. Though to a lesser degree, the glucosaminidase domain of the Auto autolysin from L. mono-
cytogenes also cleaves deacetylated muropeptides19, which rules out a substrate-assisted mechanism in 
this GH73 family member and correlates with the identification of two carboxylates essential for the 
activity: Glu122 (the general acid) and Glu156 (the general base). These two residues, located near the 
C-terminus of helix α-3 and the first strand of the β-lobe, respectively, are 13.3 Å apart and substrate 
binding must promote an important structural change to get them close enough to allow for the pro-
posed inverting mechanism19. The same scenario is foreseen for the FlgJ proteins from Sphingomonas sp. 
and Salmonella enterica, and the TM0633 protein from Thermotoga maritima, where two acidic residues 
located at equivalent positions have also been reported to be essential for the activity21,28,30. In con-
trast, the glucosaminidase module (gluatlwm) of the AtlWM autolysin, like LytB, does not have a second 
acidic residue essential for catalysis in the β-lobe, and substitution of Asp1335 (equivalent to Asp657 of 
LytB) by alanine or asparagine had a minor impact on the activity27. These data support the notion that 
GH73 glycosyl hydrolases do not share a unique catalytic mechanism, and evolution towards inverting 
Figure 7. Influence of the amino alcohol incorporated in the (lipo)TAs on the localization and chain 
dispersing activity of different LytB protein variants. Top panels, structures of choline and the tested 
analogs. Middle panels, fluorescent signals of R6 cultures grown in media with different amino alcohols 
taken after 30 min of incubation with GFP-LytBΔ 1 protein. (a) Culture in DEA-containing medium;  
(b) Culture in MEA-containing medium; (c) Culture in EA-containing medium. Bottom panels, average 
chain length of DEA, MEA or EA cells after 30 min of incubation at 37 °C with the different LytB 
constructions. Error bars and asterisks mean as in Fig. 6 (*P < 0.05; **P < 0.01). Bars, 4 μ m.
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or substrate-assisted enzymes might be related to the length and/or the structure of the β-lobe that helps 
to shape the catalytic cavity22, thereby facilitating a fine-tuning of target substrates.
LytB acts exclusively at the poles of the cells, both endogenously and exogenously. Our results revealed, 
however, that LytB can solubilize as much as 36% of the PG when fragments of deacetylated cell walls 
are used as substrate, in agreement with previous findings13, and that its activity on cell walls pretreated 
with LytA compared with that of LytC. This raises the possibility that LytB could potentially act as an 
autolytic enzyme whose activity should be strictly controlled to prevent the lysis of the cell. Indeed, the 
failure to clone the gene fragment encoding the full-length form of LytB (with the signal peptide) in 
Escherichia coli is consistent with the notion that the unregulated mature protein, when located on the 
outer surface of the cytoplasmic membrane, could cause the lysis of the culture, as was shown in the cases 
of endolysins of pneumococcal bacteriophages EJ-1 and Cpl-113. However, more evidence is needed to 
ascertain whether or not LytB might have the capacity to act as an autolytic enzyme, a role so far assigned 
to LytA and LytC. Our results indicate that LytB activity is controlled by at least three different mecha-
nisms including: (i) choline-independent physical confinement at the cell pole regions; (ii) attachment to 
choline moieties of (lipo)TAs through the LytBCBD domain; and (iii) PG composition (selective control of 
susceptible bonds through deacetylation of the GlcNAc moieties and PG cross-linking).
The differences found in the electron density of lateral walls with respect to the cell poles suggested 
that they are structurally and/or chemically distinct13. Therefore, preferential location of LytB around 
the poles could rely on the specific recognition of an unevenly distributed/accessible targets facilitated 
by LytBCBD, as no binding of GFP-LytBCAT to R6B cells was detected. Moreover, the PG itself could 
behave as a selective, irregular structural entity where differences in pore dimensions might determine 
LytB localization or the target accession, considering the size and probable asymmetry of the overall 
protein structure. It is also plausible that certain components of the bacterial envelope, like (lipo)TAs or 
surface proteins, could cooperate to shape the selectivity of LytB by masking susceptible bonds in vivo. 
As in other choline-binding proteins22,23, the LytBCBD probably provides a strong binding to the bacte-
rial surface through multiple noncovalent bonds, thereby impairing LytB transit across the PG matrix. 
Elucidation of the overall protein co-structure with cell wall fragments would be needed to know if 
LytBCBD contributes to the substrate specificity or to the proper orientation of the PG chain within the 
catalytic cavity.
Methods
Bacterial strains and growth conditions. The bacterial strains, plasmids and oligonucleotides used 
in this study are listed in Table  1 and Supplementary Table S1, respectively. S. pneumoniae was grown 
at 37 °C in C medium supplemented with yeast extract (0.8 mg/ml; Difco Laboratories; C + Y medium) 
without shaking48. Bacteria with TAs containing the various amino alcohol residues (such as choline, 
EA, MEA, or DEA) were grown for more than 20 generations in Cden medium supplemented with the 
appropriate amino alcohol49. E. coli was grown in Luria-Bertani (LB) medium at 37 °C with shaking.
Cloning, expression and purification of proteins. Routine DNA manipulations were performed 
essentially as described previously50. To construct the single alanine mutants of LytB (Glu585, Asp596, 
Asp607, Asp618, Asp619, Asp621, Glu633, Asp637, Glu653, Asp657, Glu662 and Glu673) appropriate 
oligonucleotides were used (Supplementary Table S1). Site-directed mutagenesis were performed with Pfu 
DNA polymerase (Biotools) according to the manufacturer’s instructions51 using the plasmid pRGR513 as 
template, and the recombinant plasmids were transformed into E. coli BL21(DE3). In addition, relevant 
fragments for construction of deletion mutants were cloned into the pT7-7 plasmid52 using NdeI and PstI 
for constructions without GFP, or BamHI and PstI for fusion proteins with the GFP, and the resulting 
recombinant plasmids were transformed into E. coli BL21(DE3). The accuracy of all cloned genes was 
confirmed by DNA sequencing (Secugen S.L.).
For protein overproduction, transformed E. coli cells were incubated in LB medium containing ampicil-
lin (0.1 mg/ml) to an optical density at 600 nm (OD600) of about 0.6. Isopropyl-β -D-thiogalactopyranoside 
(0.1 mM) was then added and incubation was continued overnight at 24 °C. Cells were harvested by cen-
trifugation (10,000 × g, 10 min), resuspended in 20 mM sodium phosphate buffer (hereafter Pi buffer), 
pH 6.9, and disrupted in a French pressure cell. Typically, insoluble fractions were separated by centrifu-
gation (15,000 × g, 20 min), and the supernatants were loaded onto a DEAE-cellulose column for stand-
ard purification, in a single step, according to the procedure described for choline-binding proteins53. 
Additionally, LytB wild type and the alanine mutants were subjected to a size-exclusion chromatography 
on dextran-agarose (Superdex-200, GE Healthcare) to remove possible aggregates or minor components 
of lower molecular weight. Column pre-equilibration and protein elution was carried out with 20 mM 
Pi buffer, pH 8.0, with 140 mM choline. GFP-LytBΔ 4 and GFP-LytBCAT proteins, with four and none 
CBRs, respectively, were purified by chromatography on DEAE-cellulose using a 0.5–1.5 M NaCl gradient 
for elution. Protein concentrations were determined spectrophotometrically using the molar absorption 
coefficients at 280 nm. Before use, proteins were dialyzed at 4 °C against the appropriate buffer and cen-
trifuged for 5 min at 11,600 × g.
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Isolation of pneumococcal cell wall and PG. S. pneumoniae laboratory strains R36A, the 
penicillin-resistant strains Pen6, the attenuated variant Pen6adr, and the mutant strains R6B, R36A::pgdA, 
and CS1 (Table  1) were grown to an OD620 of 0.5 in C + Y medium. Cell walls and purified PG from 
these strains were prepared as described7.
Chemicals. Oligonucleotides were purchased from IDT (Integrated DNA Technologies, Inc) or Sigma. 
The muramidase cellosyl was a gift of Hoechst (Frankfurt, Germany). (GlcNAc)n derivatives (n = 1 to 6) 
were from Toronto Research (Canada). GMDP was from Merck, and GMPP and (GM)2 were synthesized 
as described54,55.
Chain-dispersing activity assay. Chain dispersing capacity of LytB variants was assayed on pneu-
mococcal R6B cells, deficient in LytB. Cultures were grown up to an OD550 of 0.2 and then treated with 
the enzyme (10 μ g/ml) at 37 °C. Aliquots were removed at different incubation times (0.5 to 5 h) and 
examined by phase-contrast microscopy (Leica DM4000B; Microsystems); the average cell number in 
chains was also determined by counting at least 50 separate chains of cells from several independent 
experiments. Control samples contained Pi buffer (pH 6.9) instead of LytB. Each value represents the 
mean ± SD of 3 to 4 replicates. Statistical analysis was performed by using analysis of variance (ANOVA) 
for multiple comparisons. GraphPad InStat version 5.0 (GraphPad Software, San Diego, CA) was used 
for statistical analysis.
In vitro cell-wall activity assay. The cell wall degradation activity of LytB was quantitatively assayed 
at 37 °C in Pi buffer (pH 7.0) using [methyl-3H]choline-labeled pneumococcal cell walls from strain R6 
as substrate56, following the protocol described elsewhere57. To test the effect of peptide stem removal 
on LytB activity, cell walls (20 μ l) were pre-treated for 15 min at 37 °C with low concentrations of LytA 
amidase (6.0–250 ng/ml). The reaction was stopped by heating for 5 min at 100 °C and samples were 
centrifuged at 4 °C (2 min, 10,000 × g) before treating with LytB (23 μ g/ml). The mixture was incubated 
at 37 °C for further 15 min and LytB activity was determined by comparing the radioactivity in the 
supernatant with controls where the LytA amidase or LytB were substituted by buffer during the first and 
second incubation rounds, respectively. One unit of activity (U) was defined as the amount of enzyme 
that catalyses the hydrolysis (solubilization) of 1 μ g of cell wall material in 10 min.
Characterization of cell-wall hydrolysis products. Muropeptides released from the pneumococ-
cal cell walls by LytB were reduced and analyzed by HPLC following a previously published procedure7 
with certain modifications. In parallel, PG was digested with the muramidase cellosyl that is used to 
determine muropeptide composition7. PG suspensions (~0.25 mg in 200 μ l) were stirred with 10 μ g of 
cellosyl in 20 mM Pi buffer (pH 4.8), and cell walls (~0.40 mg in 200 μ l) with 20 μ g of LytB in Pi buffer 
(pH 7.0) supplemented with 100 mM sodium chloride. After 24 h at 37 °C new enzyme was added, and 
the hydrolysis proceeded for another 24 h. Reactions were stopped by either heating 10 min at 100 °C 
(cellosyl) or cooling at 4 °C (LytB). Samples were then processed and separated on a reverse-phase col-
umn (Prontosil 120-3-C18-AQ, 250 × 4.6 mm, 3 μ m, Bischoff, Germany) as described7. The total peak 
area (excluding the salt fractions eluting before 8 min) was normalized to 100%, and the relative area 
of the products determined. Selected fractions were collected for electrospray ionization-tandem mass 
spectrometry analysis (ESI-MS/MS) at the Newcastle University Pinnacle facility using a Finnigan LTQ- 
FT mass spectrometer58.
Cleavage of PG structural analogues. The capacity of LytB to hydrolyze GlcNAc oligomers (chiti-
nase activity) or PG derivatives was evaluated by HPLC and mass spectrometry using (GlcNAc)4, 
(GlcNAc)5, GMDP, GMPP and (GM)2 (Supplementary Fig. S5) as potential substrates. Reaction mixtures 
containing LytB and the assayed compounds were incubated at 37 °C in Pi buffer, pH 7.0, using protein/
substrate molar ratios of 1:20–1:375 with similar results. At selected times, aliquots were withdrawn 
and the reaction stopped by cooling at 4 °C (GlcNAc oligomers) or adding 20 μ l of formic acid in 0.05% 
acetonitrile (v/v) (muropeptides). Controls without LytB were run in parallel.
Hydrolysis of (GlcNAc)4, (GlcNAc)5, GMDP and GMPP was analyzed by HPLC on a reversed-phase 
column (Tracer Excel 120 ODS-B, 250 × 4 mm, 5 μ m, Teknokroma) using a Shimadzu LC-10AV VP 
instrument. Samples (35 μ l) were eluted at 20 °C using a linear 30-min gradient from buffer A (50 mM 
sodium phosphate (pH 4.2) and 15 μ M NaN3) to buffer B (75 mM sodium phosphate (pH 4.92) and 
15% methanol) for GlcNAc oligomers, whereas for synthetic muropeptides a 40-min gradient from 2% 
to 15% of acetonitrile in 0.1% trifluoroacetic acid was used59. The flow was 0.5 ml/min and compounds 
were detected at 205 nm. Reaction products were also checked by MALDI-TOF mass spectrometry in a 
Voyager DE-PRO mass spectrometer (Applied Biosystems) in the reflector positive ion mode using the 
following conditions: 20–25 kV acceleration voltage, 72–94% grid voltage, 0.001–0.05% guide wire volt-
age, and 200–400 ns of delay time reflector60. The spectra were obtained over an m/z range of 100–7000 
and external mass calibration was applied using des-Arg1 bradykinin and angiotensin I of Calibration 
Mixture 1 (Sequazyme Peptide Mass Standards Kit; Applied Biosystems).
www.nature.com/scientificreports/
1 5Scientific RepoRts | 5:16198 | DOi: 10.1038/srep16198
Hydrolysis of (GM)2 was analysed by LC/MS on a reversed-phase column (Acquity UPLC HSS T3, 
150 × 2.1 mm, 1.8 μ m, Waters) using a Dionex Ultimate 3000 Rapid Separation UPLC system with a 
Dionex Ultimate 3000 photodiode array detector coupled with a Bruker MicrOTOF-Q II quadrupole 
time-of-flight hybrid mass spectrometer. Detailed LC/MS and LC/MS/MS conditions were described 
previously61. Samples were eluted at 40 °C using a linear 15-min gradient from 0% to 5% of acetonitrile 
in 0.1% formic acid.
Docking studies. Docking studies were performed with the AutoDock 4.2 program62 using 
GlcNAc-MurNAc-L-Ala as a first ligand and the atomic coordinates of the LytBCAT fragment depos-
ited in the Protein Data Bank entry 4Q2W17. The protein was considered rigid and the ligand flexible. 
The GlcNAc-MurNAc-L-Ala structure was carefully built using the Pymol visualizer (PyMOL Molecular 
Graphics System, Version 1.5.0.4 Schrödinger, LLC) followed by molecule optimization and energy 
minimization using the PRODRG2 server63. Ligand and protein files were edited and prepared with 
AutoDockTools 1.5.6 program62. Polar hydrogens and Kollman charges were added to LytB structure. 
Gasteiger charges were computed for the ligand, whose active torsion angles were allowed to rotate dur-
ing docking. A grid box centered in the catalytic residue Glu585 with 54 × 60 × 56 grid points spaced 
0.375 Å was prepared to calculate the affinity maps of the ligand in the active site using the AutoGrid4 
program. For docking simulations, 100 Lamarckian Genetic Algorithm simulation runs were performed 
with 25 million energy evaluations per run. The best docking solution was selected by clustering within 
the default 2.0 Å rmsd value, and ranking the largest cluster solutions by the free energy AutoDock scor-
ing function. Finally, the selected ligand–receptor binding mode was processed by adding hydrogens and 
minimizing with the FF1064 and GLYCAM0665 force fields using the Amber12 package.
To construct the model of the hexasaccharide tripentapeptide (GMPP)3 in complex with LytBCAT, the 
NMR 3D structure of (GMPP)242 (Supplementary Fig. S5) was superimposed twice onto the LytBCAT/
GlcNAc-MurNAc-L-Ala model using PyMOL. First, the reducing-end was extended by two saccha-
ride units via structural superimposition of the GlcNAc1-MurNAc1 units of (GMPP)2 onto the docked 
GlcNAc-MurNAc-L-Ala muropeptide, followed by ten thousand steps of steeped descent and conjugate 
gradient energy minimization using the Amber12 software64. The same procedure was then repeated, 
but overlapping with the GlcNAc2-MurNAc2 units of (GMPP)2 onto the GlcNAc-MurNAc-L-Ala ligand 
in order to extend the non-reducing end of the glycan strand. The two partially overlapping (GMPP)2 
molecules were merged into a single fragment with three disaccharide pentapeptide units before per-
forming the last minimization. The stem peptides were allowed to move freely during all minimization 
steps. Substitution of the D-γ -Glu moiety of (GMPP)2 by D-γ -Gln did not alter the complex structure.
Miscellaneous methods. Observation of the cell morphology of pneumococci was carried out at 
the mid-exponential phase of growth by phase-contrast or epifluorescence microscopy with a Leica 
DM4000B Microsystems microscope. LigPlot+ v.1.466 was used to represent the ligand binding interac-
tions and the Dali server37 for 3D structural comparison.
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